Opdivo (nivolumab) - Ono Pharmaceutical, BMS
A Pediatric Case of Malignant Melanoma Successfully Treated With Adjuvant Nivolumab. (PubMed, J Dermatol) - Oct 20, 2026 - No abstract available 
Journal • Melanoma • Oncology • Pediatrics • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42897089
 
Akio Tanaka; Daiki Matsubara; Hayato Mizuno; Kanae Okamoto; Takanobu Kan; Takumi Sakamoto; Tetsuzo Ishikawa
 
Oct 20, 2026
 
Prev Next